05/08/2026
Iāll be totally honest: over the past six months, Iāve felt a lot of advocacy burnout.
There is a particular kind of exhaustion that comes from repeatedly sharing the hardest parts of your story, hoping that somewhere along the way it helps create a better system for the people who come after you.
But situations like this cannot be ignored.
Living with metastatic breast cancer means uncertainty is already part of my everyday life.
I donāt know what my next scan will show. I donāt know how my body will respond to treatment. I donāt know how much time I have.
But access to the treatment my oncologist recommends shouldnāt be another uncertainty I have to carry.
Yesterday, I had the honour of joining BCNA as a consumer representative and sharing my experience in front of decision-makers, alongside other incredible advocates from the breast cancer and YA cancer community.
I was there not only to speak from my own lived experience, but to represent the collective voices of so many people who felt fear, letdown, confusion and frustration when the news about Zoladex was communicated in a way that left many patients searching for answers.
We shared what this experience was really like on the ground, and why better communication matters.
Because when (sadly, not āifā) a medication is discontinued again, patients deserve to hear important information directly from the people responsible for their care and support.
I hope our feedback was heard loud and clear, and that it helps create meaningful change for the future.
Because behind every medicine, every announcement and every healthcare decision are real people whose lives are directly affected. š©·